Login
$BSX
$43.72 After hours

$BSX SEC Filings

Filed On Filing
06 Nov 2026 Form 4: Mahoney Michael F, Director

Acquired 252,241 shares (Gift)

06 Nov 2026 SCHEDULE 13G/A
03 Nov 2026 Form 4: O'Sullivan Miriam, SVP, Chief HR Officer

Received 3,871 shares by exercise or conversion · Gave up 1,872 shares to cover exercise price or tax ($78.6K)

02 Nov 2026 10-Q
28 Oct 2026 8-K: Results of Operations and Financial Condition

Marlborough, Mass. (October 28, 2026) -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $5.138 billion during the third quarter of 2026, growing 1.5 percent on a reported, operational1 and organic2 basis, all compared t...

07 Oct 2026 8-K: Departure/Election of Directors or Officers; Compensation; Other Events

New operating structure designed to increase efficiency and support continued growth

23 Sep 2026 8-K: Departure/Election of Directors or Officers; Compensation

On September 21, 2026, Arthur C. Butcher informed Boston Scientific Corporation (the “Company”) that he has decided to retire from his role as Executive Vice President and Group President, MedSurg and Asia Pacific effective as of January...

08 Sep 2026 8-K: Material Cybersecurity Incidents

As previously disclosed in a Current Report on Form 8-K filed on August 26, 2026 with the Securities and Exchange Commission, on August 25, 2026, Boston Scientific Corporation (the “Company”) identified a cybersecurity incident that affe...

03 Sep 2026 Form 4: O'Connor Padraig Andrew, EVP, Global Operations

Received 1,171 shares by exercise or conversion · Gave up 567 shares to cover exercise price or tax ($27.4K)

26 Aug 2026 Form 4: Morano Susan E, Director

Bought 2,040 shares ($100K)

26 Aug 2026 8-K: Other Events

On August 25, 2026, Boston Scientific Corporation (the “Company”) identified a cybersecurity incident affecting certain of its information technology systems that has resulted in a global disruption to the Company’s operations. Upon dete...

12 Aug 2026 Form 4: Woodworth Emily, SVP, Global Controller and CAO

Acquired 2,930 shares (Discretionary Transaction) ($150K)

11 Aug 2026 Form 4: Monson Jonathan, EVP and CFO

Acquired 9,908 shares (Discretionary Transaction) ($500K)

07 Aug 2026 Form 4: Habiger David C, Director

Bought 2,100 shares ($99.9K)

06 Aug 2026 SCHEDULE 13G/A
05 Aug 2026 Form 4: Habiger David C, Director

Bought 1,042 shares ($50.1K) · Bought 140 shares ($6.8K)

05 Aug 2026 Form 4: Mahoney Michael F, Director

Bought 186,240 shares ($9M) · Acquired 22,119 shares (Discretionary Transaction) ($1.07M)

03 Aug 2026 Form 4: Ludwig Edward J, Director

Bought 5,000 shares ($227K)

03 Aug 2026 Form 4: Fitzgerald Joseph Michael, EVP & Group Pres, Cardiology

Acquired 64,198 shares (Discretionary Transaction) ($3M)

03 Aug 2026 10-Q

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support